ArticleEuropean heart journal. Case reports2026
Superior vena cava-to-inferior vena cava bridging stent technique for cavo-atrial junction stenosis: a case series.
Article in European heart journal. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Endovascular bridging stents are relatively underreported but effective methods to increase the diameter of stenosed segments of the superior and inferior cavo-atrial junction. This case report describes the use of superior to inferior vena cava bridging stents to resolve cavo-atrial junction stenoses in three patients with distinct mediastinal masses. Case Summary: All patients presented symptomatically with shortness of breath, as well as lower limb oedema, facial and neck swelling, and/or a cough. SVC-to-IVC bridging stents were selected as the appropriate intervention for these patients due to progressive symptoms, a lack of alternatives treatment options, and the anatomical proximity of the stenoses to the right atrium. More than 30-month follow-up showed a durable response in two patients without stent-related adverse events. One patient died 5 days post-procedure of shock of unclear aetiology. Discussion: In the two cases with long-term follow-up, patients' symptoms have significantly improved, showing the effectiveness of this intervention for typically end-of-life patients. Consideration is given to the anatomical intricacies involved in the placement of stents, anticoagulation strategies, as well as the impact on future interventions. Conclusion: This series highlights the complexity of case management in patients with vena cavae stenosis, as well as the durability of bridging stent placement over a uniquely long follow-up.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.